Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemonaive NSCLC patients receiving first-line gefitinib monotherapy
Chih-Hsin Yang , Chong-Jen Yu , Jin-Yuan Shih , Yeun-Chung Chang
J Clin Oncol ( 26) 2745 -2753
9
2008
Mechanism for activation of mutated EGF receptors in lung cancer.
Monica L Red Brewer , Darson Lai , Mark A Lemmon , William Pao
Cancer Research 73 ( 8_Supplement) 1106 -1106
2013
Germinal center formation in mice lacking αβ T cells
Lee Dianda , Adam Gulbranson‐Judge , William Pao , Adrian C Hayday
European journal of immunology 26 ( 7) 1603 -1607
51
1996
of June 13, 2013.
Michael J Owen , Adrian Hayday , Li Wen , Domingo F Barber
J Immunol 160 1965 -1974
1998
Twice weekly pulse and daily continuous dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers and brain metastases
Kathryn C Arbour , Mark G Kris , Gregory J Riely , Ai Ni
Cancer 124 ( 1) 105 -105
1
2018
Afatinib plus cetuximab delays resistance compared to single-agent erlotinib or afatinib in mouse models of TKI-naive EGFR L858R-induced lung adenocarcinoma
Valentina Pirazzoli , Deborah Ayeni , Catherine B Meador , Basavaraju G Sanganahalli
Clinical cancer research 22 ( 2) 426 -435
51
2016
Molecular Determinants of Acquired Clinical Resistance to Erlotinib and Gefitinib in Non-Small-Cell Lung Cancer
Herbert F Oettgen Gomez , Christopher G Azzoli , J Gregory , Megan Dunne Riely
IRB 4 ( 103A) 1 -1
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as
Dina Polosukhina , Harold D Love , Hernan Correa , Zengliu Su
固形がんの TKI 獲得耐性: 肺がんによる知見
D Ross Camidge , William Pao , Lecia V Sequist
Nature reviews. Cancer, clinical oncology 5 ( 1) 1 -10
2015
Targeted therapies: Afatinib—new therapy option for EGFR-mutant lung cancer
A Yu Helena , William Pao
Nature reviews Clinical oncology 10 ( 10) 551 -551
93
2013
Preclinical development of a selective, potent small molecule ALK inhibitor
Christine M Lovly , Elisa de Stanchina , Chris Liang , William Pao
Cancer Research 70 ( 8_Supplement) 1788 -1788
5
2010
A kinome-wide siRNA screen identifies modifiers of sensitivity to the EGFR T790M-targeted tyrosine kinase inhibitor (TKI), AZD9291, in EGFR mutant lung adenocarcinoma
Eiki Ichihara , Joshua A Bauer , Pengcheng Lu , Fei Ye
Cancer Research 75 ( 15_Supplement) 768 -768
2015
Elucidating the mechanisms of acquired resistance in lung adenocarcinomas
Sandra Ortiz-Cuaran , Lynnette Fernandez-Cuesta , Christine M Lovly , Marc Bos
Cancer Research 75 ( 15_Supplement) 752 -752
2015
Epidural Abscess and Vertebral Osteomyelitis caused by Listeria monocytogenes: Case Report and Literature Review
Kamran M Khan , William Pao , Jason Kendler
Scandinavian Journal of Infectious Diseases 33 ( 9) 714 -716
13
2001
“Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non-Small-Cell Lung Cancer,”
Vincent A Miller , Mark G Kris , Neelam Shah , Jyoti Patel
Oncology Times 26 ( 11) 69 -70
944
2004
Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors
Katerina Politi , Maureen F Zakowski , Pang-Dian Fan , Emily A Schonfeld
Genes & Development 20 ( 11) 1496 -1510
386
2006
Methods and compositions for detecting a drug resistant EGFR mutant
Harold Varmus , Katerina Politi , William Pao , Vincent Miller
58
2011
Discovery of novel allosteric EGFR L858R inhibitors for the treatment of non-small-cell lung cancer as a single agent or in combination with osimertinib
Ulrike Obst-Sander , Antonio Ricci , Bernd Kuhn , Thomas Friess
Journal of medicinal chemistry 65 ( 19) 13052 -13073
12
2022
A new target for therapy in squamous cell carcinoma of the lung
Kadoaki Ohashi , William Pao
Cancer discovery 1 ( 1) 23 -24
11
2011
Methods and compositions for detecting a drug resistant EGFR mutant
Harold Varmus , Katerina Politi , William Pao , Vincent Miller
4
2013